Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

Journal of Clinical Investigation

Volumn 99, Issue 6, 1997, Pages 1295-1301

  Mann, Michael J ^a,b   Gibbons, Gary H ^a   Tsao, Philip S ^c   Von Der Leyen, Heiko E ^c   Cooke, John P ^c   Buitrago, Ricardo ^c   Kernoff, Rachel ^c   Dzau, Victor J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antisense oligonucleotides; cardiovascular surgery; cell cycle; endothelium; gene therapy

Indexed keywords

ACETYLCHOLINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIMYCIN; CYCLINE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL REACTIVITY; CELL CYCLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN GRAFT;

EID: 0030893643     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119288     Document Type: Article

References (39)

1. Campeau, L., M. Enjalbert, J. Lesperance, M.C. Bourassa, P. Kwiterowich, S. Wacholder, and A. Sniderman. 1984. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation: A study 10 years after aortocoronary bypass surgery. N. Engl. J. Med. 311:1329-1334.
2. Brewster, D.C., A.J. LaSalle, J.G. Robinson, E.C. Strayhorn, and C.R. Darling. 1983. Factors affecting patency of femeropopliteal bypass grafts. Surg. Gynecol. & Obstet. 157:437-442.
3. Mann, M.J., G.H. Gibbons, R.S. Kernoff, F.P. Diet, P. Tsao, J.P. Cooke, Y. Kaneda, and V. J. Dzau. 1995. Genetic engineering of vein grafts resistant to atherosclerosis. Proc. Natl. Acad. Sci. USA. 92:4502-4506.
4. Chester, A.H., G.S. O'Neil, S. Moncada, S. Tadjkarimi, and M.H. Yacoub. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 336:897-900.
5. Bossaller, C., G.B. Habib, H. Yamamoto, C. Williams, S. Wells, and P.D. Henry. 1987. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest. 79:170-174.
6. Verbeuren, T.J., F.H. Jordaens, L.L. Zonnekeyn, C.E. Van Hove, M.C. Coene, and A.C. Herman. 1986. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ. Res. 58:552-564.
7. Ku, D.D., J.B. Caulfield, and J.K. Kirklin. 1991. Endothelium-dependent responses in long-term human coronary artery bypass grafts. Circulation. 83: 402-411.
8. Tanaka, H., G.K. Sukhova, S.J. Swanson, S.K. Clinton, P. Ganz, M.I. Cybulsky, and P. Libby. 1993. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 88:1788-1803.
9. Weidinger, F.F., J.M. McLenachan, M. Cybulsky, J.M. Gordon, H.A. Rennke, N.K. Hollenberg, P. Ganz, and J.P. Cooke. 1990. Persistent dysfunction of regenerated endothelium following balloon angioplasty of rabbit iliac artery. Circulation. 81:1667-1679.
10. Khan, B.V., S.S. Parthasarathy, R.W. Alexander, and R.M. Medford. 1995. Modified low-density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1262-1270.
11. Loppnow, H., and P. Libby. 1990. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest. 85:731-738.
12. Galis, Z.S., M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, E.N. Unemori, M.W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181-189.
13. Clinton, S.K., and P. Libby. 1992. Cytokines and growth factors in atherogenesis. Arch. Path. Lab. Med. 116:1292-1300.
14. Cooke, J.P., A.H. Singer, P. Tsao, P. Zera, R.A. Rowan, and M.E. Billingham. 1992. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-1172.
15. von der Leyen, H.E., G.H. Gibbons, R. Morishita, N.P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J.P. Cooke, and V.J. Dzau. 1995. Gene therapy inhibiting neointimal vascular lesion: In vivo gene transfer of endothelial-cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1137-1141.
16. Morishita, R., G.H. Gibbons, K.E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V.J. Dzau. 1993. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA. 90: 8474-8478.
17. Zwolak, R.M., M.C. Adams, and A.W. Clowes. 1987. Kinetics of vein graft hyperplasia: association with tangential stress. J. Vasc. Surg. 5:126-136.
18. Cooke, J.P., A.M. Singer, P. Tsao, P. Zera, R.A. Rowan, and M.E. Billingham. 1992. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-1172.
19. Tsao, P.S., L.M. McEvoy, H. Drexler, E.C. Butcher, and J.P. Cooke. 1994. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 89:2176-2182.
20. Klyachkin, M.L., M.G. Davies, E. Svendsen, J.H. Kim, M.F. Massey, L. Barber, R.L. McCann, and P.-O. Hagen. 1993. Hypercholesterolemia and experimental vein grafts: Acclerated development of intimal hyperplasia and an increase in abnormal vasomotor function. J. Surg. Res. 54:451-468.
21. Ohara, Y., T.E. Peterson, and D.G. Harrison. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91: 2546-2551.
22. Cybulsky, M.L. and M. A. Gimbrone, Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (Wash. DC). 251:788-791.
23. Berkenboom, G., P. Unger P. and J. Fontaine. 1989. Atherosclerosis and responses of human isolated coronary arteries to endothelium-deffendent and-independent vasodilators. J. Cardiovasc. Pharmacol. 14:35-39.
24. Forstermann, U., A. Mugge, U. Alheid, A. Haverich, and J.C. Frolich. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ. Res. 62:185-190.
25. Jayakody, L., M. Senaratne, A. Thomson, and T. Kappagoda. 1987. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ. Res. 60:251-264.
26. Lüscher, T.F., D. Diederich, R. Stiebmann, K. Lehmann, P. Stultz, L. von Segesser, Z. Yang, M. Turina, E. Grädel, E. Weber, and F.R. Bühler. 1988. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N. Engl. J. Med. 319:462-467.
27. Oneil, G.S., A.H. Chester, C.J. Schyns, S. Tadjkarimi, J.A.A. Borland, and M.H. Yacoub. 1994. Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. J. Thorac. Cardiovasc. Surg. 107:699-706.
28. Cross, K.S., M.G. Davies, M.N. El-Sanadiki, J.J. Murray, E.M. Mikat, and P.-O. Hagen. 1994. Long-term human vein graft contractility and morphology: a functional and histopathological study of retrieved coronary vein grafts. Br. J. Surg. 81:699-705.
29. Park, T.C., C.T. Harker, J.M. Edwards, G.L. Moneta, L.M. Taylor, and J.M. Porter. 1993. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses. J. Vasc. Surg. 18:61-69.
30. Cross, K.S., M.N. El-Sanadiki, J.J. Murray, E.M. Mikat, R.L. McCann, and P.-O. Hagen. 1988. Functional abnormalities of experimental autologous vein graft neoendothelium. Ann. Surg. 208:631-638.
31. Davies, M.G., M.L. Klyachkin, H. Dalen, E. Svendsen, and P.-O. Hagen. 1993. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts. Surgery (St. Louis). 114:258-271.
32. Hassoun, P.M., F.S. Yu, J.J. Zulueta, A.C. White, and J.J. Lanzillo. 1995. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am. J. Physiol. 268:809-817.
33. Munzel, T., H. Sayegh, B.A. Freeman, M.M. Tarpey, and D.G. Harrison. 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95:187-194.
34. Niu, X.F., C.W. Smith, and P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1133-1140.
35. Marui, N., M.K. Offermann, R. Swerlick, C. Kunsch, C.A. Rosen, M. Ahmad, R.W. Alexander, and R.M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866-1874.
36. DeCaterina, R., P. Libby, H.-B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A. Gimbrone, Jr., W.S. Shin, and L.K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest. 96:60-68.
37. Tsao, P.S., R. Buitrago, J.R. Chan, and J.P. Cooke. 1996. Fluid flow inhibits endothelial adhesiveness: NO and transcriptional regulation of VCAM-1. Circulation. 94:1682-1689.
38. Zeiher, A.M., B. Fisslthaler, B. Schray-Utz, and R. Busse. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76:980-986.
39. Kohler, T.R., T.R. Kirkman, D. Gordon, and A.W. Clowes. 1990. Mechanism of long-term degeneration of arterialized vein grafts. Am. J. Surg. 160: 257-261.